Latest Insider Transactions at Illumina, Inc. (ILMN)
This section provides a real-time view of insider transactions for Illumina, Inc. (ILMN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ILLUMINA, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ILLUMINA, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 05
2022
|
Kevin Carl Pegels Chief of Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-1.78%
|
$45,375
$363.84 P/Share
|
|
Mar 28
2022
|
Charles Dadswell SVP, General Counsel |
SELL
Open market or private sale
|
Indirect |
368
-4.51%
|
$125,856
$342.83 P/Share
|
|
Mar 01
2022
|
Charles Dadswell SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Indirect |
2,082
+20.32%
|
-
|
|
Mar 01
2022
|
Phillip G. Febbo SVP Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,029
+27.73%
|
-
|
|
Mar 01
2022
|
Joydeep Goswami SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,082
+19.89%
|
-
|
|
Mar 01
2022
|
Aimee L Hoyt SVP, Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,082
+21.03%
|
-
|
|
Mar 01
2022
|
Kevin Carl Pegels Chief of Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
1,515
+17.71%
|
-
|
|
Mar 01
2022
|
Kathryne Gambrell Reeves SVP, Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,082
+31.78%
|
-
|
|
Mar 01
2022
|
Sam Samad SVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,082
+15.56%
|
-
|
|
Mar 01
2022
|
Jose Torres VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
969
+34.78%
|
-
|
|
Feb 22
2022
|
Charles Dadswell SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,808
-22.92%
|
$576,752
$319.86 P/Share
|
|
Feb 22
2022
|
Charles Dadswell SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,561
+36.63%
|
-
|
|
Feb 22
2022
|
Phillip G. Febbo SVP Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,002
-17.08%
|
$319,638
$319.86 P/Share
|
|
Feb 22
2022
|
Phillip G. Febbo SVP Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,851
+32.71%
|
-
|
|
Feb 22
2022
|
Joydeep Goswami SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,521
-19.44%
|
$485,199
$319.86 P/Share
|
|
Feb 22
2022
|
Joydeep Goswami SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,979
+33.71%
|
-
|
|
Feb 22
2022
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
944
-14.14%
|
$301,136
$319.86 P/Share
|
|
Feb 22
2022
|
Aimee L Hoyt SVP, Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,421
+33.87%
|
-
|
|
Feb 22
2022
|
Kevin Carl Pegels Chief of Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
386
-6.53%
|
$123,134
$319.86 P/Share
|
|
Feb 22
2022
|
Kevin Carl Pegels Chief of Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,065
+15.27%
|
-
|
|
Feb 22
2022
|
Sam Samad SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,808
-16.4%
|
$576,752
$319.86 P/Share
|
|
Feb 22
2022
|
Sam Samad SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,561
+29.27%
|
-
|
|
Feb 22
2022
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,808
-4.12%
|
$576,752
$319.86 P/Share
|
|
Feb 22
2022
|
Susan H Tousi SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,561
+9.41%
|
-
|
|
Feb 22
2022
|
Francis A De Souza President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,144
-10.32%
|
$2,916,936
$319.86 P/Share
|
|
Feb 22
2022
|
Francis A De Souza President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,383
+17.95%
|
-
|
|
Jan 12
2022
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
800
-2.0%
|
$340,000
$425.0 P/Share
|
|
Jan 08
2022
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
115
-3.46%
|
$41,630
$362.28 P/Share
|
|
Dec 28
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
100
-0.25%
|
$38,700
$387.06 P/Share
|
|
Dec 22
2021
|
Charles Dadswell SVP, General Counsel |
SELL
Open market or private sale
|
Indirect |
322
-8.93%
|
$122,360
$380.29 P/Share
|
|
Dec 08
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
100
-0.25%
|
$37,500
$375.0 P/Share
|
|
Nov 22
2021
|
Charles Dadswell SVP, General Counsel |
SELL
Open market or private sale
|
Indirect |
314
-8.01%
|
$118,378
$377.86 P/Share
|
|
Nov 12
2021
|
Alexander Aravanis SVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
361
-8.04%
|
$139,346
$386.35 P/Share
|
|
Nov 08
2021
|
Phillip G. Febbo SVP Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,000
-24.91%
|
$406,000
$406.83 P/Share
|
|
Nov 05
2021
|
Alexander Aravanis SVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
191
-4.08%
|
$77,928
$408.14 P/Share
|
|
Nov 05
2021
|
Charles Dadswell SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Indirect |
739
-15.87%
|
$301,512
$408.14 P/Share
|
|
Nov 05
2021
|
Phillip G. Febbo SVP Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
446
-10.0%
|
$181,968
$408.14 P/Share
|
|
Nov 05
2021
|
Joydeep Goswami SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
264
-6.51%
|
$107,712
$408.14 P/Share
|
|
Nov 05
2021
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
434
-11.55%
|
$177,072
$408.14 P/Share
|
|
Nov 05
2021
|
Sam Samad SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
723
-10.06%
|
$294,984
$408.14 P/Share
|
|
Nov 05
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
982
-2.38%
|
$400,656
$408.14 P/Share
|
|
Nov 05
2021
|
Francis A De Souza President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,604
-4.95%
|
$1,470,432
$408.14 P/Share
|
|
Nov 05
2021
|
Kevin Carl Pegels Chief of Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
574
-10.59%
|
$234,192
$408.14 P/Share
|
|
Nov 05
2021
|
Kathryne Gambrell Reeves SVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
97
-3.91%
|
$39,576
$408.14 P/Share
|
|
Nov 02
2021
|
Alexander Aravanis SVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,926
-6.67%
|
$1,205,512
$412.96 P/Share
|
|
Oct 28
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
100
-0.24%
|
$41,400
$414.35 P/Share
|
|
Oct 26
2021
|
Alexander Aravanis SVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,926
-27.78%
|
$1,237,698
$423.0 P/Share
|
|
Oct 22
2021
|
Charles Dadswell SVP, General Counsel |
SELL
Open market or private sale
|
Indirect |
314
-6.32%
|
$129,054
$411.0 P/Share
|
|
Oct 19
2021
|
Alexander Aravanis SVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,926
-4.74%
|
$1,205,512
$412.46 P/Share
|
|
Oct 12
2021
|
Alexander Aravanis SVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,926
-3.84%
|
$1,196,734
$409.37 P/Share
|